CVE:VMD Viemed Healthcare (VMD) Stock Price, News & Analysis C$4.95 -0.10 (-1.98%) (As of 05/25/2018) Add Compare Share Share Stock Analysis Stock Analysis About Viemed Healthcare Stock (CVE:VMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Viemed Healthcare alerts:Sign Up Key Stats Today's RangeC$4.84▼C$5.0550-Day RangeC$4.95▼C$4.9552-Week RangeC$1.65▼C$5.34Volume91,383 shsAverage Volume197,608 shsMarket CapitalizationC$187.65 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewViemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States. It offers respiratory services and related equipment, including non-invasive ventilators, positive airway pressure machines, and oxygen units, as well as services of respiratory therapists. The company also provides in-home sleep apnea testing to determine the existence of sleep apnea at home. In addition, it leases equipment, including non-invasive ventilators, bi-level devices and CPaP, percussion vests, and various supplies and peripheral equipment, as well as sells medical equipment and patient monitoring services. Further, the company provides therapy, education, and counseling to patients in their homes using technology. Viemed Healthcare, Inc. is headquartered in Lafayette, Louisiana.Read More… Receive VMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address VMD Stock News HeadlinesViemed Healthcare (CVE:VMD) Shares Down 2% - Should You Sell?December 18 at 1:53 AM | americanbankingnews.comViemed Healthcare Expands Amid Rising Healthcare NeedsNovember 12, 2024 | markets.businessinsider.comMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.December 19, 2024 | Brownstone Research (Ad)Viemed Healthcare, Inc. (VMD): A Bull Case TheoryNovember 12, 2024 | msn.comViemed Healthcare (NASDAQ:VMD) Stock Quotes, Forecast and News SummaryOctober 12, 2024 | benzinga.comViemed Healthcare Inc (VMD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic ...October 9, 2024 | gurufocus.comViemed Healthcare, Inc. (NASDAQ:VMD) Q1 2024 Earnings Call TranscriptMay 8, 2024 | msn.comViemed Healthcare, Inc.: Viemed Healthcare Announces First Quarter 2024 Financial ResultsMay 7, 2024 | finanznachrichten.deSee More Headlines VMD Stock Analysis - Frequently Asked Questions How have VMD shares performed this year? Viemed Healthcare's stock was trading at C$4.95 at the beginning of the year. Since then, VMD stock has increased by 0.0% and is now trading at C$4.95. View the best growth stocks for 2024 here. How do I buy shares of Viemed Healthcare? Shares of VMD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Viemed Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Moderna (MRNA), Netflix (NFLX) and Meta Platforms (META). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolCVE:VMD CUSIPN/A CIKN/A Webwww.viemed.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares37,910,000Free FloatN/AMarket CapC$187.65 million OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (CVE:VMD) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viemed Healthcare Please log in to your account or sign up in order to add this asset to your watchlist. Share Viemed Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.